1. Impact of Graft Size Matching on the Early Post-Transplant Complications and Patients Survival in Children after Living Donor Liver Transplantations
- Author
-
I Grzelak, Waldemar Patkowski, Piotr Kaliciński, Adam Kowalski, Marek Stefanowicz, Grzegorz Kowalewski, Diana Kamińska, Hor Ismail, Krzysztof Zieniewicz, and Marek Szymczak
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,living donor ,030230 surgery ,Liver transplantation ,Pediatrics ,Living donor ,RJ1-570 ,Article ,Group B ,03 medical and health sciences ,Liver disease ,Graft size ,0302 clinical medicine ,Risk of mortality ,Medicine ,liver transplantation ,business.industry ,medicine.disease ,Post transplant ,Surgery ,graft to recipient weight ratio ,Transplantation ,Pediatrics, Perinatology and Child Health ,030211 gastroenterology & hepatology ,business - Abstract
We aimed to assess the impact of the graft-recipient weight ratio (GRWR) on early post-transplant complications and patient survival rates in children after living donor liver transplantation (LDLT). We retrospectively analyzed 321 patients who underwent LDLT from 2004 to 2019. The recipients were categorized into four groups: 37 patients had a GRWR ≤ 1.5% (Group A), 196 patients had a GRWR >, 1.5% and ≤3.5% (Group B), 73 patients had a GRWR >, 3.5% and <, 5% (Group C) and 15 patients had a GRWR ≥ 5% (Group D). Incidence of early surgical complications including vascular complications, biliary complications, postoperative bleedings, gastrointestinal perforations and graft loss were comparable among groups with a different GRWR. Delayed abdominal wound closure was more common in patients with a GRWR >, 3.5%. Recipients with a GRWR <, 5% had a significantly better prognosis concerning patients and graft survival. Using grafts with a GRWR <, 5% allows us to expand the donor pool and decrease the risk of mortality while on the waiting list, when patients at the time of transplantation have less advanced liver disease. LDLT with a GRWR ≥ 5% is related to a higher risk of poor outcome, and thus should be an option for treating selected patients when the risk of a delayed transplantation is high and access to deceased donors is limited.
- Published
- 2021